Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$15.36 - $25.0 $1.25 Million - $2.04 Million
-81,418 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$22.56 - $29.68 $3.6 Million - $4.73 Million
-159,380 Reduced 66.19%
81,418 $1.84 Million
Q2 2021

Aug 16, 2021

BUY
$24.96 - $41.25 $603,233 - $996,930
24,168 Added 11.16%
240,798 $6.2 Million
Q1 2021

May 12, 2021

BUY
$28.0 - $53.42 $6.07 Million - $11.6 Million
216,630 New
216,630 $9.03 Million

Others Institutions Holding CGEM

About Cullinan Oncology, Inc.


  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $613M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.